Open vs ultrasound-guided carpal tunnel release ( CTS )
Official title: Prospective Multicenter Trial Comparing Open Surgical Decompression Versus Minimally Invasive Ultrasound-Guided Carpal Tunnel Release
Run by AUVA General Trauma Hospital Salzburg · NCT07814547 · Data updated 2026-11-12
This study compares two surgical approaches for carpal tunnel syndrome to see which helps people recover better after surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | AUVA General Trauma Hospital Salzburg Academic / other |
| Locations | 2 sites (Salzburg and 1 other locations) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | June 30, 2028 |
| Study ends | July 2028 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07814547 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with electrophysiologically confirmed carpal tunnel syndrome who have exhausted conservative treatments and are planned for surgical release.
✕Probably not a fit
Patients with prior surgery at the same site, non-CTS nerve conditions, or contraindications to either procedure may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, prospective observational study follows patients undergoing either open surgical carpal tunnel release or ultrasound-guided release. Centers assign treatment based on their standard practice rather than randomization, with 200 participants split evenly between the two cohorts. Participants are assessed before surgery and at 2 weeks, 6 weeks, 3 months, and 12 months after the procedure to evaluate functional recovery, symptoms, pain, return to work, satisfaction, and complications. The analysis focuses on clinical outcomes, patient-reported outcomes, and socioeconomic impact. The aim is to understand whether the less invasive ultrasound-guided approach offers advantages over the traditional open procedure in real-world settings.
Why it matters
Potential benefit: If successful, patients may experience faster recovery, less postoperative pain, and better return-to-work timelines with ultrasound-guided release.
How similar studies have gone: Previous nonrandomized studies have explored both approaches; this observational study adds real-world comparative data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Electrophysiologically verified Carpal Tunnel Syndrome by EMG/nerve conduction studies, with the examination not older than 6 months at the time of inclusion. * Previous documented and exhausted conservative treatment * Existing indication for surgery that has been discussed with the patient and the patient's explicit wish to undergo surgical treatment. * Ability to provide informed consent and written informed consent * Age ≥18 years. Exclusion Criteria: * Previous surgery at the affected location or revision procedures. * Pre-existing nerve lesions of the upper extremity, including traumatic transections or proximal injuries. * Manifest polyneuropathy. * Foreseeable loss to follow-up, for example inability to contact the participant or insufficient compliance, before the critical 3-month follow-up. * Age under 18 years.
Where it's running
-
AUVA General Trauma Hospital Salzburg
Salzburg, Austria Recruiting -
University Institute of Radiology, Paracelsus Medical Private University Salzburg
Salzburg, Austria Recruiting
Study contacts
- Study coordinator: Alexander M.T. Paszicsnyek, Dr.
- Email: alexander.paszicsnyek@auva.at
- Phone: +43 5939344211
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Injection for Carpal Tunnel Syndrome: Hyaluronic Acid vs Corticosteroid vs 5% Glucose
This study tests three ultrasound-guided injections (hyaluronic acid, corticosteroid, and 5% glucose) to see which best helps adults with mild to moderate carpal tunnel syndrome.
-
Amniotic Membrane and Secretome Added to Carpal Tunnel Release
This trial tests whether adding amniotic membrane and secretome to carpal tunnel surgery helps people with moderate-to-severe CTS recover better than surgery alone.
-
Reliability and validity of hand function tests in carpal tunnel syndrome
This study tests whether three hand function tests (JTHFT, MDT, and Nine-Hole Peg Test) are reliable and valid for people with carpal tunnel syndrome.
-
Neuromobilization, Tendon Gliding, or Both for Mild to Moderate Carpal Tunnel Syndrome
This trial tests whether neuromobilization, tendon gliding exercises, or a combination of both help reduce pain and improve hand function in people with mild to moderate carpal tunnel syndrome.
-
MeDe: Carpal tunnel release with added lacertus release vs carpal tunnel release alone
In adults with carpal tunnel syndrome, this trial tests whether adding a lacertus fibrosus release to the standard carpal tunnel release helps reduce symptoms and improve hand function.
-
Effect of peripheral repetitive magnetic stimulation on elbow or wrist pain
This pilot study tests whether two days of active peripheral repetitive magnetic stimulation can reduce pain in adults with tennis/golfer’s elbow or carpal tunnel syndrome, compared with a sham treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.